What Researchers Did
Researchers established an international multicenter registry in 2011 to prospectively collect outcomes and complications data for hyperbaric oxygen therapy for both approved and selected unapproved indications.
What They Found
Data from 22 centers on 2,880 patients showed that delayed radiation injury was the most common UHMS-approved indication for hyperbaric oxygen therapy. Quality of life, head and neck radiation symptoms, wound scores, and hearing significantly improved after treatment, with low complication rates.
What This Means for Canadian Patients
Canadian patients undergoing hyperbaric oxygen therapy for conditions like delayed radiation injury or non-healing wounds may experience improved quality of life and symptom reduction. This therapy appears to be a safe and effective treatment option, with a low risk of complications, for a range of indications.
Canadian Relevance
This study has no direct Canadian connection as it is an international registry without specified Canadian participation.
Study Limitations
As a registry, the study may be limited by potential variability in data collection methods and patient selection across participating centers.